B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis
- Kieron Dunleavy,
- Frances Hakim,
- Hyun Kyung Kim,
- John E. Janik,
- Nicole Grant,
- Takayuki Nakayama
- Unknown,
- National Institutes of Health
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>The occurrence of delayed neutropenia following rituximab is poorly defined and of unknown cause. We hypothesized it may be related to perturbations of stromal derived factor-1 (SDF-1) and granulocyte homeostasis. Late-onset neutropenia (LON) was investigated in 130 patients with untreated aggressive B-cell lymphoma receiving DA-EPOCH (dose-adjusted etoposide, prednisone, Oncovin [vincristine], cyclophosphamide, and hydroxydaunorubicin) chemotherapy with or without rituximab. All patients were in remission and had no known causes for neutropenia. LON occurred in 6 (8%) of 76 patients receiving rituximab and 0 of 54 patients not receiving rituximab (P = .04). The median onset was 175 days (range, 77-204 days) after treatment with a median duration of 14 days (range, 11-16 days). In a subset of 24 patients, a significant correlation was found between rapid B-cell recovery and granulocyte decline over the 6-month recovery period (R = -0.53; P = .04). Rapid B-cell recovery directly correlated with prerecovery SDF-1 levels (R = 0.65; P = .015) and SDF-1 decline (R = -0.67; P = .013) after recovery. Our results suggest that early B-cell lymphopoiesis is important for B-cell recovery following rituximab, and that perturbation of SDF-1 during B-cell recovery retards neutrophil egress from the bone marrow. These findings illustrate the dual role of SDF-1 in human B-cell and granulocyte homeostasis.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 795-802 (8 pages)Journal (Volume, Issue Number)
Blood (Volume 106, Issue 3)Publication milestones
- Published - 08/01/2005
Publication status
Published - 08/01/2005
ISSN
0006-4971Publication IDs
- Scopus: 23044502336
- PubMed: 15718416
Publication metrics
Metrics
SciVal
citations
84
SciVal
FWCI
1.62
SciVal
Author count
12
SciVal
Paper percentile
93
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.08
Fractional count
11
Fractional count
0.92
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
120
Captures
61
Funding Details
FunderFunding number
NCI
ZIABC010728
